Dysregulated GLP-1 signaling is centrally implicated in type 2 diabetes mellitus (T2D) and obesity, and GLP-1based therapies have shown benefit in reducing hyperglycemia, body weight, and some cardiovascular risk markers
Wegovy works effectively without a gallbladder and may help prevent the 3-5% weight gain commonly seen after gallbladder removal surgery
This study was funded by research grants from the National Science Council, Taiwan, Republic of China (MOST 106-2314-B-182A-060 -MY2
Low blood sugar (Hypoglycemia): A possible side effect of weight loss injections, especially in patients using insulin or with diabetes
This highlights the suggested additional efficacy of incretin dual agonists over GLP-1R mono-agonists
A structured approach that includes ketogenic or low-carb nutrition, resistance training, and metabolic tracking may help maintain weight loss and promote long-term metabolic health.